Dow Jones

40,444.82

0.39%

Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Get Started

Home
Investing
Stocks
UK
LSE
Celadon Pharmaceuticals Plc (CEL)
Celadon Pharmaceuticals Plc (CEL) News

CEL Celadon Pharmaceuticals Plc

61.00

1.50 (2.52%)

22 Jul 2024 - Closed

Delayed by 15 minutes

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Celadon Pharmaceuticals Plc	LSE:CEL	London	Ordinary Share	GB00BDQYGP38	ORD 1P

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	1.50	2.52%	61.00	57.00	65.00	61.00	59.50	59.50	12,246	14:00:11

Industry Sector	Turnover	Profit	EPS - Basic	PE Ratio	Market Cap
Investment Advice	149k	-7.14M	-0.1082	-5.64	39.26M

Director/PDMR Shareholding

04/08/2005 9:00am

UK Regulatory

RNS Number:7129P
Celsis International PLC
04 August 2005


                            Celsis International PLC


                                 Share Options


4 August 2005: Celsis International plc today announces that following the
adoption of the Share Performance Plan at the Annual General Meeting held on 26
July 2005, Jay LeCoque, Chief Executive and Christian Madrolle, Finance
Director, have respectively been awarded 525,575 and 405,600 Share Options at a
price of 1p per share on 26 July 2005.


These Share Options are subject to the achievement of performance criteria as
detailed in the Share Performance Plan.


Enquiries:

Celsis International plc                                      Tel: 01638 600 151
Christian Madrolle, Finance Director & Company Secretary
Jenny Parsons, Corporate Communications


Financial Dynamics                                            Tel: 020 7831 3113
David Yates
Lucy Briggs


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

RDSBIGDIGGGGGUX